Delivery Order HHSD200200100081I-HHSD2002001000810025

The Centers for Disease Control and Prevention (CDC) awarded a $4,455,976 cost-no-fee definitive contract to The Regents of the University of California, San Francisco (UCSF) to develop, implement, and evaluate interventions to improve latent tuberculosis infection (LTBI) identification and treatment among high-risk non-U.S.-born populations in primary care settings. This contract, known as Tuberculosis Epidemiologic Studies Consortium III (TBESC3), has a period of performance from September 29,...

Duke University, as prime contractor, was awarded a $4.3 million delivery order against the Tuberculosis Epidemiology Studies Consortium master IDIQ by the Centers for Disease Control and Prevention. The contract calls for enrollment, preventive treatment, data collection and analysis of latent tuberculosis infection patients. Major subcontractors include Atrium Health and Vanderbilt University, which will assist with performance of the clinical work. The goal of the project appears to be...

Research Triangle Institute (RTI) International was awarded a $707,813 time and materials contract by the Department of Health and Human Services Centers for Disease Control and Prevention to provide cost effectiveness analysis services for the Tuberculosis Epidemiologic Studies Consortium III (TBESC-III). The contract calls for RTI to design and implement cost effectiveness analyses of clinical interventions to improve performance across the latent tuberculosis infection care cascade. RTI...

This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) to the Maryland Department of Health Vital Statistics Administration Division, a U.S. state government entity, to support the Tuberculosis Epidemiology Studies Consortium. The contract has a ceiling value of $4,178,577.57 and runs through September 2021. It is a cost-no-fee contract type, with no set-aside designation. The contract provides for a comparison of tuberculin skin tests (TST) versus...

The Centers for Disease Control and Prevention (CDC) awarded a definitive cost-no-fee contract valued at $3.78M to Denver Health and Hospital Authority for tuberculosis trials and consortium services. The contract, effective January 1, 2021, and extending through December 31, 2030, supports clinical research activities under the CDC's broader tuberculosis prevention and treatment initiatives. Denver Health will serve as a participating site in the Tuberculosis Trials Consortium, conducting...

The Centers for Disease Control and Prevention (CDC) Pittsburgh division awarded a $10.67 million cost-reimbursable contract to King County's Public Health-Seattle & King County division on January 1, 2021, with a completion date of December 31, 2030. This definitive contract, awarded competitively with no set-aside designation, supports tuberculosis clinical trials and consortium services. The primary deliverables include participation in clinical research studies, adherence to study...

The U.S. Department of Health and Human Services (HHS) awarded a $5,099,064.36 delivery order contract to Denver Health and Hospital Authority (Denver Health) to conduct a study comparing tuberculosis skin tests (TST) and interferon-gamma release assays (IGRAs) in latent tuberculosis infection (LTBI) patients. The contract was issued under the Tuberculosis Epidemiology Studies Consortium, a larger indefinite delivery vehicle held by HHS. The award did not utilize any set-aside designations....

The Centers for Disease Control and Prevention (CDC) awarded a $4,679,587.20 Definitive Contract to the Denver Health and Hospital Authority (Denver Health) to develop, implement, and evaluate intervention studies to improve identification of latent tuberculosis infection (LTBI) and treatment-to-cure for high-risk non-U.S.-born populations in primary care settings. This contract, which does not have a set-aside designation, has a period of performance from September 29, 2021 through March 28,...

This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Emory University, a private research institution in Atlanta, Georgia. The $170,704.03 cost-no-fee delivery order is for a project titled "TB Mortality in the U.S.: Epidemiology and Prevention Opportunities." The contract has no set-aside designation and has an ultimate completion date of September 28, 2011. Emory University, through its Office of Sponsored...

This is a $2,054,175.16 federal contract awarded by the Centers for Disease Control and Prevention (CDC) to PPD Development LP, a global contract research organization (CRO), for monitoring services in support of the Tuberculosis Trials Consortium (TBTC). The contract is a 5-year definitive contract with a time and materials pricing type. It will involve on-site monitoring, quality assurance, investigational product management, and reporting for TBTC clinical trials of new drugs, diagnostics,...